Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is -48.29% lower on its value in year-to-date trading and has touched a low of $4.55 and a high of $26.98 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RCKT stock was last observed hovering at around $6.72 in the last trading session, with the day’s loss setting it -0.22%.
Currently trading at $6.50, the stock is -8.23% and -8.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.24 million and changing -3.35% at the moment leaves the stock -50.08% off its SMA200. RCKT registered -72.20% loss for a year compared to 6-month loss of -59.45%.
The stock witnessed a 5.69% gain in the last 1 month and extending the period to 3 months gives it a -37.92%, and is -7.01% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.28% over the week and 9.87% over the month.
Rocket Pharmaceuticals Inc (RCKT) has around 299 employees, a market worth around $700.30M and $0.00M in sales. Distance from 52-week low is 42.86% and -75.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-59.37%).
with sales reaching $4.36M over the same period.The EPS is expected to grow by 14.65% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Rocket Pharmaceuticals Inc (RCKT) Top Institutional Holders
The shares outstanding are 106.75M, and float is at 99.76M with Short Float at 12.29%.
The top institutional shareholder in the company is RTW INVESTMENTS, LP with over 17.69 million shares valued at $380.82 million. The investor’s holdings represent 18.8677% of the RCKT Shares outstanding. As of 2024-06-30, the second largest holder is WELLINGTON MANAGEMENT GROUP LLP with 9.16 million shares valued at $197.12 million to account for 9.7665 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.19 million shares representing 6.6057% and valued at over $133.33 million, while VANGUARD GROUP INC holds 6.196 of the shares totaling 5.81 million with a market value of $125.06 million.
Rocket Pharmaceuticals Inc (RCKT) Insider Activity
#####
Still, SEC filings show that on May 16 ’25, Wilson Martin (Officer) Proposed Sale 946 shares at an average price of $6.53 for $6175.0. The insider now directly holds shares of Rocket Pharmaceuticals Inc (RCKT).
